Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07459920) titled 'Cannabis extrAct in Oncology Patients for the Treatment of TUmor Related Symptom Burden' on March 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Supportive Care. Masking: Double (Participant, Investigator).
Primary Sponsor: National Cancer Institute, Naples
Condition:
Advanced Malignant Solid Tumor
Intervention:
Drug: Cannabis Extract Oil
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: April 1, 2026
Target Sample Size: 156
Countries of Recruitment:
Italy
To know more, visit https://clinicaltrial...